Gluten Sensitivity Market to Witness Upsurge in Growth During the Forecast Period 2030, Examine DelveInsight | Key Companies – ImmunoGenX, Takeda, Provention Bio, Falk Pharma, Zedira, and Others

December 14 22:24 2021
Gluten Sensitivity Market to Witness Upsurge in Growth During the Forecast Period 2030, Examine DelveInsight | Key Companies - ImmunoGenX, Takeda, Provention Bio, Falk Pharma, Zedira, and Others
Delveinsight Business Research LLP
DelveInsight’s “Gluten Sensitivity Market Insights, Epidemiology, and Market Forecast 2030” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology as well as the Gluten Sensitivity Market Size and Share in the 7MM (i.e. the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Gluten Sensitivity market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2017 to 2030. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Gluten Sensitivity Market

Gluten Sensitivity: An Overview

Gluten sensitivity, also called gluten intolerance, non-celiac gluten sensitivity (NCGS), or non-celiac wheat sensitivity (NCWS), is a disorder where the body reacts badly to eating gluten. It is characterized by intestinal and extra-intestinal symptoms related to the ingestion of gluten-containing foods in the absence of celiac disease (CD) and wheat allergy. 

The treatment for celiac disease is adhering to a strict gluten-free diet. The treatment for a wheat allergy is to adhere to a strict wheat-free diet. If a patient has NCGS, the extent to which they need to eliminate gluten from their lifestyle depends on the severity of the symptoms and their own tolerance level.

Gluten Sensitivity Market Key Facts

  • The total prevalent population of CD in the seven major markets was 6,450,607 in 2020 which is anticipated to increase at a CAGR of 0.53% during the study period (2018–2030).

  • The total 7MM diagnosed prevalent cases of CD in 2020 were 1,403,779 out of which the highest diagnosed prevalent cases of this disease were in the United States, which was 701,718 at a CAGR of 2.0% during the study period (2018–2030).

  • As per DelveInsight, females are affected more than males in the case of Gluten Sensitivity.

Key Benefits of Gluten Sensitivity Market Report

  • The report provides an in-depth analysis of Gluten Sensitivity Market Size and Share till 2030 in the seven major markets.

  • The report will help in developing business strategies by understanding the Gluten Sensitivity Market Trends, key players, and ongoing developments that shape and drive the market growth in the upcoming years.

  • It covers Gluten Sensitivity current treatment practices, emerging drugs, market share of the individual therapies in the 7MM.

  • The report provides a detailed assessment of the Gluten Sensitivity market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Gluten Sensitivity Market 

The market size of Celiac Disease (CD) in the seven major markets was USD 1,333.5 Million in 2020 which is anticipated to increase at a CAGR of 9.77% during the study period.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Gluten Sensitivity market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology. 

The report gives a thorough detail of the Gluten Sensitivity market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.

Get the PDF Sample of the Report @ Gluten Sensitivity Therapeutics Market

Gluten Sensitivity Epidemiology

The epidemiology section covers insights about the historical and current Gluten Sensitivity patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Gluten Sensitivity Epidemiology Segmentation

  • Total Prevalent Population of Gluten Sensitivity (NCGS, and CD)

  • Diagnosed and Treatable Population of Gluten Sensitivity

  • Gender-specific Prevalent Population of Gluten Sensitivity

Gluten Sensitivity Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gluten Sensitivity market or expected to get launched in the market during the study period. The analysis covers Gluten Sensitivity market uptake by drugs; patient uptake by therapies; and sales of each drug. 

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Gluten Sensitivity Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.

Gluten Sensitivity Therapeutics Analysis

The dynamics of the Gluten Sensitivity market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the disease, incremental healthcare spending across the world, and the expected launch of emerging therapies.

Some of the key companies in the Gluten Sensitivity Market include:

  • ImmunoGenX

  • Takeda

  • 9 Meters Biopharma

  • Provention Bio

  • Falk Pharma

  • Zedira,

  • Precigen ActoBio

  • Nemysis

and others 

Gluten Sensitivity Therapies covered in the report includes:

  • ZED1227

  • TAK-062

  • E40-02

  • Latiglutenase (IMGX003)

  • Larazotide Acetate

  • CNP-101/ TAK-101

  • PRV-015 (AMG 714)

And many more

Get More Detailed Insights into the Emerging Therapies & Key Companies @

Table of Content

1. Key Insights

2. Executive Summary 

3. Gluten Sensitivity Competitive Intelligence Analysis

4. Gluten Sensitivity Market Overview at a Glance

5. Gluten Sensitivity Disease Background and Overview

6. Gluten Sensitivity Patient Journey

7. Gluten Sensitivity Epidemiology and Patient Population

8. Gluten Sensitivity Treatment Algorithm, Current Treatment, and Medical Practices

9. Gluten Sensitivity Unmet Needs

10. Key Endpoints of Gluten Sensitivity Treatment

11. Gluten Sensitivity Marketed Products

12. Gluten Sensitivity Emerging Therapies

13. Gluten Sensitivity Seven Major Market Analysis

14. Attribute Analysis

15. Gluten Sensitivity Market Outlook (7 major markets)

16. Gluten Sensitivity Access and Reimbursement Overview

17. KOL Views on the Gluten Sensitivity Market.

18. Gluten Sensitivity Market Drivers

19. Gluten Sensitivity Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Request Sample Report here:-

Latest Reports By DelveInsight

Chronic Insomnia Market

DelveInsight’ s “Chronic Insomnia Market Insights, Epidemiology and Market Forecast – 2030” report provides a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology and the Chronic Insomnia market size, share, trends, and forecast for the seven major markets (i.e. the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States